Join the Anemia group to help and get support from people like you.
Anemia News
Anemia In Pregnancy Increases Risk Of Heart Defects
THURSDAY, April 24, 2025 – Treating anemia during pregnancy might lower the risk of heart defects in newborns, a new study says. Women with anemia in early pregnancy have a 47% increased risk of...
Maternal Anemia in Early Pregnancy May Increase Risk for Congenital Heart Disease
WEDNESDAY, April 23, 2025 – Maternal anemia in early pregnancy is associated with an increased risk for congenital heart disease (CHD) in offspring, according to a study published online April 23 in...
Six-Month Mortality Lower With Liberal Transfusion Strategy in Acute MI With Anemia
MONDAY, Jan. 6, 2025 – For patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not differ with a restrictive versus liberal transfusion...
More Than Half of People With Rheumatoid Arthritis Have Anemia
THURSDAY, Jan. 2, 2025 – Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus. Jamal Shah, M.B.B.S., from Khyber Teaching ...
Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia
FRIDAY, Dec. 27, 2024 – A blood transfusion following a heart attack could be a life-saving measure for patients with anemia. A new evidence review published in the journal NEJM Evidence shows...
American Society of Hematology, Dec. 7 to 10
The annual meeting of the American Society of Hematology was held from Dec. 7 to 10 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical ...
Overall Prevalence of Anemia 9.3 Percent in August 2021 to August 2023
WEDNESDAY, Dec. 4, 2024 – During August 2021 to August 2023, the overall prevalence of anemia was 9.3 percent among people aged 2 years and older, according to a December data brief published by the...
Study Looks at Efficacy of Hemoglobin Thresholds for Transfusion
TUESDAY, Oct. 1, 2024 – For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with lower hemoglobin thresholds for transfusion,...
FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
Approval is for use in myelofibrosis patients with anemia regardless of prior myelofibrosis therapy Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease,...
U.S. FDA Approves Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
PRINCETON, N.J.--(BUSINESS WIRE) August 28, 2023-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the...
FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia
May 15, 2018 – The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney...